INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice

Sameer Sharma, Lixian Chen, Tianhao Zhou, Meenakshi Chawla, Anita Ganjoo, Shunichiro Okada, Salvatore Alesci, Krishnan Nandabalan, Heather Francis

Open source

DOI: 10.3389/fmed.2026.1840071
Published: 2026-06-09
Container: Frontiers in Medicine
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2026.1840071,
  title = {INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice},
  author = {Sameer Sharma and Lixian Chen and Tianhao Zhou and Meenakshi Chawla and Anita Ganjoo and Shunichiro Okada and Salvatore Alesci and Krishnan Nandabalan and Heather Francis},
  year = {2026},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2026.1840071},
  url = {https://doi.org/10.3389/fmed.2026.1840071}
}

RIS

TY  - JOUR
TI  - INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice
AU  - Sameer Sharma
AU  - Lixian Chen
AU  - Tianhao Zhou
AU  - Meenakshi Chawla
AU  - Anita Ganjoo
AU  - Shunichiro Okada
AU  - Salvatore Alesci
AU  - Krishnan Nandabalan
AU  - Heather Francis
PY  - 2026
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1840071
UR  - https://doi.org/10.3389/fmed.2026.1840071
ER  -

APA

Sharma, S., Chen, L., Zhou, T., Chawla, M., Ganjoo, A., Okada, S., Alesci, S., Nandabalan, K., & Francis, H. (2026). INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1840071

Source records

crossref · retrieved 2026-09-27T14:16:04.901Z